A key step during viral reactivation from latency is the re-expression of viral genes. 33
Introduction 63
Reactivation of latent human cytomegalovirus (HCMV) infection poses a 64 significant threat to patients with compromised immune systems. While primary 65 infections in healthy adults are typically associated with little or mild disease, 66 reactivation in immunocompromised individuals, such as solid organ and stem cell 67 transplant recipients and can lead to significant morbidity and mortality (1) . Despite this, 68
little is known regarding the mechanisms controlling HCMV reactivation. 69
Following an initial burst of viral gene expression upon entering cells that support 70 latency (e.g. CD34 + hematopoietic stem cells; HPCs), HCMV gene expression is largely 71 silenced, allowing the virus to persist in a quiescent or latent state(2, 3). Pro-72 inflammatory cytokines and cellular cues that drive differentiation induce the re-73 expression of viral lytic cycle genes, culminating in the production of infectious virus that 74 can spread throughout the host and cause disease (4, 5) . Critical to HCMV reactivation 75 is the re-expression of the viral immediate early 1 and 2 proteins (IE1 and IE2), which 76 drive the expression of the HCMV lytic cycle (6) (7) (8) . Defining factors that regulate IE1 and 77 IE2 expression during reactivation is thus critical for understanding the mechanisms 78 controlling reactivation and resulting HCMV disease. 79
In cells permissive for lytic replication such as fibroblasts, the expression of both 80 IE1 and IE2 transcripts is largely driven by the major immediate early promoter (MIEP), 81 which is silenced during latency. Until recently it was presumed that reactivation of the 82 lytic cycle relied on the resumption of MIEP activity. However we recently discovered 83 two alternative promoters (iP1 and iP2, together referred to as intronic promoters) within 84 the first intron of the canonical major immediate early locus (9) . Rather than inducing 85 MIEP activity, HCMV reactivation stimuli instead induce transcription from the iP1 and 86 iP2 promoters, which correlates with the increase in IE1 and IE2 mRNA levels (10) . 87
Deletion of the intronic promoters significantly attenuates the production of infectious 88 virus after reactivation, revealing that the iP1 and iP2 promoters play critical roles in IE1 89 and IE2 re-expression and HCMV reactivation. 90
Here we begin to unravel the mechanisms by which HCMV senses cellular cues 91 to trigger IE1 and IE2 re-expression by defining FOXO transcription factors as key players linking cellular differentiation to HCMV reactivation. These data provide new 93 mechanistic insights into HCMV reactivation and suggest that manipulating FOXO 94 transcription factor activity may be a future means to limit HCMV disease. (BAC) containing an SV40 promoter-driven GFP reporter (11) was used as wild type 102 virus, and served as the backbone for the generation of recombinant viruses. Titers of 103 cell free virus were determined by the 50% tissue culture infective dose (TCID50) 104 method on MRC-5 fibroblasts. Unless otherwise noted, all infections were performed at 105 a multiplicity of infection (MOI) of 1 for one hour, followed by removal of the inoculum. 106 107 Construction of Recombinant Viruses. BAC-mediated recombineering was used to 108 generate viral mutants on the TB40E genomic background using a two-step 109 recombination approach, as before (9). Briefly, the iP2 locus was replaced with a 110 kanamycin/levansucrase fusion cassette (KanSacB) using homology mediated 111 recombination in recombination competent SW105 E.coli (12). The KanSacB cassette 112 was then replaced with the iP2 sequences containing the indicated mutation in a second 113 round of recombination. The entire genomes of the wild type and recombinant BACs 114 were then sequenced to ensure no additional changes were present other than the 115 intended mutations. 116 117 THP-1 Latency Model. Latency studies were conducted essentially as described 118 previously (10, 13, 14) . Briefly, cells were with HCMV (TB40/E; (5, 15)) at a multiplicity 119 of 2. After 5 days cells were treated with 100 nM 12-o-tetradecanoylphorbol-13-acetate 120 (TPA) to induce reactivation, or with DMSO solvent control. Whole cell lysates, DNA, 121 and RNA were collected at each of the indicated time points. pure populations of CD34 + HPCs were infected with TB40E WT or FOXO3mut123 125 recombinant virus (MOI = 2). Twenty-four hours after infection, latently infected cells 126 were purified and co-cultured with stromal cells to maintain latent infection (10, 14) . 127
After 10 days, latently infected cells were co-cultured with naïve MRC-5 fibroblast 128 monolayers to quantify the number of infectious centers produced. Only sites with a threshold p value of p<.01 were considered. 169
170
Results 171
172
We recently described a novel mechanism by which the re-expression of the IE1 173 and IE2 mRNAs during HCMV reactivation is driven by the alternative promoters iP1 174 and iP2 ( Fig 1A) , rather than the MIEP (10). While iP1 and iP2 promoters are necessary 175 for efficient reactivation, the factors regulating their activity are unknown. Reactivation is 176 induced by differentiation of monocytes into macrophages, a process that is mimicked in 177 experimental latency models by treating latently infected cells with phorbol esters (e.g., 178
TPA) (10) or LY294002 (20), a chemical inhibitor of the PI3K/mTOR pathway. A 179 literature review found that phorbol esters, LY294002, and monocyte differentiation all 180 activate FOXO family of transcription factors (21). An in silico analysis of the HCMV MIE 181 locus identified three potential FOXO binding sites upstream of iP2 ( Fig 1B) , the most 182 active MIE promoter during reactivation (10). We thus hypothesized that FOXO and IE2 mRNAs and HCMV reactivation. 185
To test this hypothesis, we first determined if FOXO transcription factors (TFs) 186 stimulated the activity of the iP1 and iP2 promoters outside the context of infection. We 187 co-transfected vectors expressing FOXO1 and FOXO3a with reporter constructs 188 containing the distal promoter (dP), MIEP, iP1, or iP2 promoters upstream of luciferase. 189
We found neither FOXO1 nor FOXO3a affected the activity of the MIEP or the dP, but 190 both FOXO1 or FOXO3a significantly increased the activity of both iP1 and iP2 ( Fig  191   2A,B ). We mutated critical nucleotides in each potential FOXO binding site in iP2, the 192 most FOXO-responsive promoter, (shown in Fig 1B) , and also generated a reporter [22] [23] [24] . In this construct, the 202 MIEP is the predominant promoter driving IE1 and IE2 transcription, and both iP1 and 203 iP2 are minimally active (9). We found expression of FOXO3a, but not FOXO1, resulted 204 in a slight, but reproducible, increase in IE1 and IE2 protein levels ( Fig S1) . 205
To confirm that FOXO TFs increase IE1 and IE2 expression independently of 206 MIEP, we repeated the above experiments using a variant of the pSVH plasmid where 207 the core MIEP is deleted (pSVHΔMIEP). We previously showed that IE1 and IE2 208 expression from this plasmid is driven exclusively by the iP1 and iP2 promoters (9). As 209 before, deleting the core MIEP promoter greatly decreased IE1 and IE2 protein levels 210 ( Fig. 3A) . In contrast to the luciferase reporters, FOXO1 expression had minimal affect 211 on IE1 or IE2 protein levels in this setting. However, FOXO3a expression significantly 212 increased IE1 and IE2 protein levels ( Fig 3A) . Surprisingly IE1 and IE2 protein levels presence of FOXO3a (Fig. 3A) . 215
As FOXO1 had minimal impact on IE1/2 expression in the context of the MIE 216 locus, we focused further studies on FOXO3a. Mutating any of the potential FOXO TF 217 binding sites abrogated the effects of FOXO3a on IE1 and IE2 protein ( Fig 3B) and 218 mRNA levels ( Fig 3C) . The increase in IE1 and IE2 mRNA correlated with a matching 219 increase in transcription from the iP1 and iP2 promoters ( Fig 3C) , suggesting that 220
FOXO3a increases IE1 and IE2 expression by stimulating iP1 and iP2 activity. FOXO Site 3 exhibiting the greatest binding (Fig 1 & 4A) . Mutating each of the potential 226
FOXO sites using the same strategy as above decreased FOXO3a binding to each site 227 (Fig A,B) . Together with the results above, these data show FOXO3a can directly bind 228 specific sequences within the iP2 promoter, suggesting that the effect of FOXO3a on 229 IE1 and IE2 expression is not due to an indirect effect on other cellular pathways. 230
We next sought to define the role of FOXO TF stimulation of the iPs in HCMV 231 reactivation. We considered depleting FOXO TFs from latently infected cells, however 232
FOXO TFs play critical roles in cellular differentiation (25). Therefore any reactivation 233 phenotypes found in FOXO-depleted, latently infected cells could be due to defects in 234 differentiation, defects in intronic promoter activation, or both. To circumvent this issue, 235
we generated a recombinant virus containing mutations in the FOXO binding sites in iP2 236 and measured the effects on virus replication and latency. In fibroblasts the recombinant 237 virus expressed viral immediate early (IE), early (E), and late (L) proteins (Fig. S2B ) 238 similarly to the wild type virus control, and replicated to equivalent titer and with similar 239 kinetics as wild type virus in fibroblasts (Fig. S2A) . These results are consistent with our 240 previous results showing a minor role for iP1 and iP2 in HCMV lytic replication in 241 fibroblasts (9, 10). 242
To determine the role of FOXO binding to the iP1 and iP2 promoters in regulating 243 IE1 and IE2 expression in hematopoietic cells, we infected THP-1 cells, a model system for HCMV latency studies, with wild type virus or the recombinant containing mutations 245 in all three FOXO binding sites. THP-1 cells are an established model of HCMV latency 246 and reactivation, which we previously used to demonstrate a requirement for iP1 and 247 iP2 in reactivation ( Fig 5A) The homogeneity of THP-1 cells offers the advantage of a 248 synchronous establishment of latency and re-expression of MIE genes following a 249 reactivation stimulus (TPA) that is not possible with primary hematopoietic cells. THP-1 250 cells were infected to similar levels with WT and mutant virus, as determined by the 251 percentage of GFP-positive cells ( Fig 5B) . Similar to infection with viruses lacking the 252 entire iP1 and iP2 elements (10), mutating FOXO binding sites in iP2 decreased IE 253 protein accumulation immediately after infection and prior to the establishment of 254 latency. In cells allowed to establish a quiescent infection, the recombinant virus also 255 expressed significantly less IE1 and IE2 protein ( Fig 5C) after the addition of TPA, a 256 reactivation stimulus. As previously shown, transcripts derived from the MIEP remained 257 very low both before and after TPA treatment of cells infected with wild type virus, and 258 importantly MIEP-derived transcript levels were not significantly affected by the absence 259 of the FOXO binding sites. In contrast, iP1 and iP2 transcripts accumulated to high 260 levels in cells infected with wild type virus before being silenced for latency, and were 261 induced following TPA stimulation (Fig 5D) . iP1 and iP2 transcripts were expressed to 262 significantly lower levels in cells infected with the FOXO binding site mutant relative to 263 the wild type virus over the time course, and were re-expressed to lower levels following 264 TPA treatment. From these data we conclude that FOXO binding sites in the intronic 265 promoters play an important role in the initial early burst of MIE expression, and TPA-266
induced MIE re-expression in THP-1 cells. 267
We also compared wild type and FOXO binding site mutant virus reactivation in 268 primary CD34 + bone marrow-derived HPCs, the gold standard model for HCMV latency 269 studies (26-28). Pure populations of infected CD34+ HPCs were isolated and cultured 270 for 10 days. The frequency of infectious centers were quantified following reactivation or 271 in a lysate prepared prior to reactivation. We observed a significant decrease in the 272 amount of infectious virus produced following reactivation of the recombinant virus as 273 compared to wild type virus ( Fig 6) . Together these data show that while dispensable for reactivation. 276 277
Discussion 278
Contrary to the long-held paradigm that viral MIE gene re-expression during 279 reactivation requires the MIEP, we recently discovered two novel promoters in the MIE 280 locus, iP1 and iP2 (9), that are necessary for IE gene re-expression and HCMV 281 reactivation (10). Here we begin to unravel the regulatory mechanisms controlling iP1 HPCs (25). Further, FOXO3a directly binds specific sequences in the intronic promoters 297 (Fig 4) and strongly increases their activity (Fig 2) . While additional studies are needed 298 to more fully elucidate the role of specific FOXO TFs in HCMV biology, these data 299 suggest that FOXO3a is a particularly crucial positive regulator of viral lytic gene 300 expression in the contexts of HCMV latency and reactivation. 301
Our data also provide new insight into the roles of intronic promoters in the 302 context of latency and reactivation. While deleting either iP1 or iP2 decreases 303 reactivation, transcripts arising from the iP2 promoter were more abundant upon 304 reactivation (10). We find that FOXO TFs are critical for IE1 and IE2 expression in iP1 and iP2 activity further suggests that transcription from these elements is 308 coordinated. Importantly, our data show that FOXO binding sites in iP1 and iP2 are 309 critical for the early burst of MIE gene expression immediately after infection of HPCs, 310 consistent with the requirement for iP1 and iP2 for efficient MIE gene expression early 311 after infection of HPCs (10). Our data also show that FOXO binding sites in the intronic 312 promoters are critical for efficient reactivation (Fig 6) , suggesting that activation of iP1 313 and iP2 by FOXO TFs is also critical for MIE gene expression during reactivation. Going 314 forward, it will be important to understand how this early burst of MIE gene expression 315 impacts latent infection and reactivation, and how FOXO TFs regulate MIE expression 316 during different stages of infection. 317
While we define a role for FOXO TFs in reactivation, our data also suggest 318 additional factors regulate intronic promoter activity and HCMV reactivation, as mutation 319 of all three FOXO binding sites in iP2 did not result in a complete loss of reactivation, 320
highlighting the complexity of the MIE locus. Several transcription factors are implicated 321 in reactivation (7, 8, (32) (33) (34) suggesting they may also regulate intronic promoter activity. 322 THP-1 cells were infected with TB40/E WT or FOXOmut123. At 5 dpi, cells were treated with TPA to stimulate macrophage differentiation and re-expression of viral genes, or with a DMSO vehicle control. (B) Equal infection (GFP+) of THP-1 cells with each virus was determined by flow cytometric analysis at 24 hpi. Biological replicates are represented as single points around the mean. Standard error is shown. (C) Cellular lysates were harvested at the indicated time points and immunoblotted to detect HCMV IE1 and IE2 and tubulin, as a loading control. (D) MIE transcripts derived from the MIEP, iP1, or iP2 were quantified using qRT-PCR relative to the low-abundance housekeeping gene H6PD. Error bars represent the average of three independent experiments, each in triplicate. The standard error of the mean is shown. Significant differences in the number of iP1 and iP2 transcripts (but not MIEP) were found at 1, 3, and 5 dpi and 7, 8, and 9 dpi with TPA (p ≤0.05). 
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